Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Osmak

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cell Biology and Toxicology|November 15, 2006
Lithium increases expression of p21(WAF/Cip1) and survivin in human glioblastoma cellsD Karlovic, S Jakopec, K Dubravcic, et al.
Anticancer Research|February 1, 2000
Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasisM Osmak, D Niksíc, A Brozović, et al.
Endodontics & Dental Traumatology|February 24, 2001
Cytotoxic effect of four root filling materialsI Miletić, I Anić, Z Karlović, et al.
Neoplasma|March 27, 2001
Diazenes as modificators of drug-resistance in tumor cellsM Osmak, T Bordukalo, A A Ristov, et al.
Neoplasma|January 16, 1999
Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cellsM Osmak, A Brozović, A Ambriović-Ristov, et al.
International Endodontic Journal|May 20, 2003
Examination of cytotoxicity and mutagenicity of AH26 and AH Plus sealersI Miletić, S Jukić, I Anić, et al.
Neoplasma|January 1, 1997
Glutathione S-transferase activity as an early marker for malignant tumors of corpus uteriM Osmak, D Babić, M Abramić, et al.
Neoplasma|December 29, 1999
Diazenes: modificators of tumor cell resistance to cisplatinM Osmak, T Bordukalo, J Kosmrlj, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1989
Defect of NK activity in children with untreated acute lymphocytic leukemia (ALL). I. Dependence on the blast count and phenotype, and response to exogenous and endogenous alpha-interferonJ Gabrilovac, L Rajić, I Martin-Kleiner, et al.
Neoplasma|January 1, 1997
Characterization of human breast adenocarcinoma SK-BR-3 cells resistant to doxorubicinM Osmak, S Kapitanović, I Vrhovec, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cell Biology and Toxicology|November 15, 2006
Lithium increases expression of p21(WAF/Cip1) and survivin in human glioblastoma cellsD Karlovic, S Jakopec, K Dubravcic, et al.
Anticancer Research|February 1, 2000
Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasisM Osmak, D Niksíc, A Brozović, et al.
Endodontics & Dental Traumatology|February 24, 2001
Cytotoxic effect of four root filling materialsI Miletić, I Anić, Z Karlović, et al.
Neoplasma|March 27, 2001
Diazenes as modificators of drug-resistance in tumor cellsM Osmak, T Bordukalo, A A Ristov, et al.
Neoplasma|January 16, 1999
Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cellsM Osmak, A Brozović, A Ambriović-Ristov, et al.
International Endodontic Journal|May 20, 2003
Examination of cytotoxicity and mutagenicity of AH26 and AH Plus sealersI Miletić, S Jukić, I Anić, et al.
Neoplasma|January 1, 1997
Glutathione S-transferase activity as an early marker for malignant tumors of corpus uteriM Osmak, D Babić, M Abramić, et al.
Neoplasma|December 29, 1999
Diazenes: modificators of tumor cell resistance to cisplatinM Osmak, T Bordukalo, J Kosmrlj, et al.
Journal of Clinical & Laboratory Immunology|May 1, 1989
Defect of NK activity in children with untreated acute lymphocytic leukemia (ALL). I. Dependence on the blast count and phenotype, and response to exogenous and endogenous alpha-interferonJ Gabrilovac, L Rajić, I Martin-Kleiner, et al.
Neoplasma|January 1, 1997
Characterization of human breast adenocarcinoma SK-BR-3 cells resistant to doxorubicinM Osmak, S Kapitanović, I Vrhovec, et al.
Pageof 7